NCT01227863

Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

Randomized Clinical Trial Of Drug Topics Efficacy Maxinom® (Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate - Lab. Union Chemical) And Maxitrol® (Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate - Lab. Alcon) In Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 70 (estimated)
• Sponsor: Azidus Brasil · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary objective of this study is to evaluate, through clinical parameters, the effectiveness of your medicine topic Maxinom ® (dexamethasone, neomycin and polymyxin B - Union Chemicals), comparing it to the topical medication Maxitrol ® (dexamethasone, neomycin and polymyxin B - Alcon ) by the percentage of improvement (sustained response rate) at the end of treatment, among the products studied.

Detailed description

1. Evaluation of isolated signs and symptoms during treatment, with a record of individual scores for each parameter and observation 2. Statistical comparison of drug safety, by recording qualitative and quantitative parameters related to adverse effects occurring during treatment.

Conditions

• Bacterial Conjunctivitis
• Acute

Interventions

Type	Name	Description
DRUG	MAXINOM®	Dexamethasone...............................................0,1% Neomicyn......................................0,35% polimixyn B...................................0,1%
DRUG	Maxitrol®	Dexamethasone...............................................0,1% Neomicyn......................................0,35% Polimixyn B...................................0,1%

Timeline

• Start date: 2011-02-01
• Primary completion: 2011-02-01
• First posted: 2010-10-25
• Last updated: 2010-10-25

Locations

1 site across 1 country: Brazil